Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-19-042902
Filing Date
2019-11-12
Accepted
2019-11-12 16:06:56
Documents
79
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q prtk-10q_20190930.htm 10-Q 2169779
2 EX-31.1 prtk-ex311_10.htm EX-31.1 18160
3 EX-31.2 prtk-ex312_9.htm EX-31.2 18322
4 EX-32.1 prtk-ex321_12.htm EX-32.1 6544
5 EX-32.2 prtk-ex322_8.htm EX-32.2 6435
  Complete submission text file 0001564590-19-042902.txt   8676140

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT prtk-20190930.xml EX-101.INS 1796997
7 XBRL TAXONOMY EXTENSION SCHEMA prtk-20190930.xsd EX-101.SCH 79067
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE prtk-20190930_cal.xml EX-101.CAL 61010
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE prtk-20190930_def.xml EX-101.DEF 272584
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE prtk-20190930_lab.xml EX-101.LAB 571852
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE prtk-20190930_pre.xml EX-101.PRE 420802
Mailing Address 75 PARK PLAZA 4TH FLOOR BOSTON MA 02116
Business Address 75 PARK PLAZA 4TH FLOOR BOSTON MA 02116 (617) 807-6600
Paratek Pharmaceuticals, Inc. (Filer) CIK: 0001178711 (see all company filings)

EIN.: 330960223 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36066 | Film No.: 191209339
SIC: 2834 Pharmaceutical Preparations